FDA approves combination immunotherapy for treatment of kidney cancer – News-Medical.net
News-Medical.net |
FDA approves combination immunotherapy for treatment of kidney cancer
News-Medical.net The standard of care for kidney cancer patients continues to improve. The U.S. Food and Drug Administration granted approval to the combination of two immunotherapy drugs, ipilimumab and nivolumab, for the treatment of metastatic kidney cancer. The … FDA Approves Immunotherapy Duo for Kidney Cancer – Cure Today |
